ROTARIX

This brand name is authorized in Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, France, Hong Kong SAR China, Ireland, Italy, Japan, Lithuania, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug ROTARIX contains one active pharmaceutical ingredient (API):

1
UNII KZ3L01D2PC - HUMAN ROTAVIRUS A TYPE G1P(8) STRAIN RIX4414 LIVE ANTIGEN
 

Rotavirus vaccine is indicated for the active immunisation of infants aged 6 to 24 weeks for prevention of gastroenteritis due to rotavirus infection. In clinical trials, efficacy was demonstrated against gastro-enteritis due to rotavirus of the most common genotypes G1P [8], G2P [4], G3P [8], G4P [8] and G9P [8].

 
Read more about Rota virus

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 ROTARIX Powder and solvent for oral suspension MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J07BH01 Rota virus, live attenuated J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BH Rota virus diarrhea vaccines
Discover more medicines within J07BH01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
BR Câmara de Regulação do Mercado de Medicamentos 510618020059307
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 29094-11-09
EE Ravimiamet 1250727, 1250738, 1250749, 1250750, 1477537, 1477548, 1477559, 1477560, 1477571, 1477582, 1477593, 1791301
ES Centro de información online de medicamentos de la AEMPS 05330005IP, 05330005IP1, 05330005IP2, 05330009, 05330009IP
FR Base de données publique des médicaments 60886387
GB Medicines & Healthcare Products Regulatory Agency 346100
HK Department of Health Drug Office 54546
IT Agenzia del Farmaco 037045010, 037045022, 037045034, 037045046, 037045059, 037045061, 037045073, 037045085, 037045097, 037045109, 037045111, 037045123
JP 医薬品医療機器総合機構 631300AS1020
LT Valstybinė vaistų kontrolės tarnyba 1030731, 1030732, 1030733, 1030734, 1056565, 1056566, 1056567, 1056568, 1056569, 1056570, 1056571, 1086095
NG Registered Drug Product Database A6-0136
Switch country to Nigeria in order to find specific presentations of ROTARIX
NL Z-Index G-Standaard, PRK 108413, 204048
NZ Medicines and Medical Devices Safety Authority 11925, 13344
PL Rejestru Produktów Leczniczych 100159915, 100197347
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W51710001, W51710002, W51710003, W51710004, W53550001, W53550002, W53550003, W53550004, W53550005, W53550006, W53550007
SG Health Sciences Authority 13150P, 13743P, 13813P
TN Direction de la Pharmacie et du Médicament 7063122
TR İlaç ve Tıbbi Cihaz Kurumu 8699522967582, 8699522967599, 8699522967605, 8699522967612, 8699522967636, 8699522967643, 8699522967650
ZA Health Products Regulatory Authority 43/30.2/0290

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.